DCTH Stock Summary and Trading Ideas (Delcath Systems | NASDAQ:DCTH)

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems trades on the NASDAQ stock market under the symbol DCTH.

As of July 24, 2026, DCTH stock price declined to $12.22 with 277,162 million shares trading.

DCTH has a beta of 1.04, meaning it tends to be more sensitive to market movements. DCTH has a correlation of 0.09 to the broad based SPY ETF.

DCTH has a market cap of $421.85 million. This is considered a Small Cap stock.

Last quarter Delcath Systems reported $25 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.05.

In the last 3 years, DCTH traded as high as $18.23 and as low as $2.25.

The top ETF exchange traded funds that DCTH belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

DCTH has underperformed the market in the last year with a price return of +5.3% while the SPY ETF gained +17.7%. However, in the short term, DCTH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +14.8% vs +4.6% return in SPY. But in the last 2 weeks, DCTH shares have been beat by the market, returning -9.6% compared to an SPY return of -1.7%.

DCTH support price is $12.10 and resistance is $12.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DCTH shares will trade within this expected range on the day.